Spikevax dispersion for injection 0.1 mg/mL

Spikevax is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older.

Patient Information Leaflet

Summary of Product Characteristics

Spikevax dispersion for injection 0.2 mg/mL

Spikevax is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 years of age and older.

Patient Information Leaflet

Summary of Product Characteristics

Tools

Temperature Excursion Tool

See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.

Contact Moderna

APACmedinfo@modernatx.com